News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
734,292 Results
Type
Article (50842)
Company Profile (284)
Press Release (683166)
Section
Business (212482)
Career Advice (2128)
Deals (36562)
Drug Delivery (102)
Drug Development (83722)
Employer Resources (171)
FDA (16964)
Job Trends (15736)
News (359578)
Policy (34690)
Tag
2024 BioCapital Digital (7)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (8)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (6)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (5)
2024 Genetown Standard (10)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (7)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (6)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (2795)
Accelerated approval (2)
Adcomms (23)
Allergies (81)
Alliances (51592)
ALS (83)
Alzheimer's disease (1393)
Antibody-drug conjugate (ADC) (104)
Approvals (16945)
Artificial intelligence (235)
Autoimmune disease (12)
Automation (14)
Bankruptcy (371)
Best Places to Work (12129)
BIOSECURE Act (18)
Biosimilars (95)
Biotechnology (196)
Bladder cancer (52)
Brain cancer (25)
Breast cancer (249)
Cancer (1882)
Cardiovascular disease (149)
Career advice (1782)
Career pathing (29)
CAR-T (136)
Cell therapy (385)
Cervical cancer (16)
Clinical research (67485)
Collaboration (744)
Compensation (420)
Complete response letters (20)
COVID-19 (2717)
CRISPR (34)
C-suite (198)
Cystic fibrosis (98)
Data (1797)
Decentralized trials (2)
Denatured (24)
Depression (43)
Diabetes (236)
Diagnostics (6528)
Digital health (18)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (108)
Drug pricing (101)
Drug shortages (28)
Duchenne muscular dystrophy (72)
Earnings (88001)
Editorial (33)
Employer branding (21)
Employer resources (147)
Events (116485)
Executive appointments (623)
FDA (18001)
Featured Employer (50)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (661)
Gene editing (94)
Generative AI (24)
Gene therapy (271)
GLP-1 (718)
Government (4654)
Grass and pollen (4)
Guidances (47)
Healthcare (19934)
Huntington's disease (22)
IgA nephropathy (20)
Immunology and inflammation (94)
Indications (25)
Infectious disease (2843)
Inflammatory bowel disease (133)
Inflation Reduction Act (8)
Influenza (44)
Intellectual property (72)
Interviews (327)
IPO (16855)
IRA (41)
Job creations (4048)
Job search strategy (1520)
Kidney cancer (9)
Labor market (29)
Layoffs (460)
Leadership (15)
Legal (8459)
Liver cancer (73)
Lung cancer (274)
Lymphoma (124)
Machine learning (2)
Management (58)
Manufacturing (260)
MASH (59)
Medical device (14304)
Medtech (14309)
Mergers & acquisitions (20137)
Metabolic disorders (630)
Multiple sclerosis (63)
NASH (16)
Neurodegenerative disease (78)
Neuropsychiatric disorders (27)
Neuroscience (1861)
NextGen: Class of 2025 (6948)
Non-profit (4757)
Northern California (2282)
Now hiring (36)
Obesity (351)
Opinion (220)
Ovarian cancer (62)
Pain (76)
Pancreatic cancer (72)
Parkinson's disease (128)
Partnered (17)
Patents (185)
Patient recruitment (86)
Peanut (47)
People (59941)
Pharmaceutical (69)
Pharmacy benefit managers (19)
Phase I (20988)
Phase II (29659)
Phase III (22157)
Pipeline (848)
Podcasts (53)
Policy (105)
Postmarket research (2750)
Preclinical (8931)
Press Release (67)
Prostate cancer (89)
Psychedelics (32)
Radiopharmaceuticals (254)
Rare diseases (353)
Real estate (6303)
Recruiting (65)
Regulatory (23482)
Reports (43)
Research institute (2494)
Resumes & cover letters (365)
Rett syndrome (3)
RNA editing (2)
RSV (39)
Schizophrenia (68)
Series A (115)
Series B (71)
Service/supplier (13)
Sickle cell disease (50)
Southern California (1973)
Special edition (14)
Sponsored (31)
Startups (3830)
State (2)
Stomach cancer (13)
Supply chain (61)
The Weekly (28)
United States (20414)
Vaccines (681)
Venture capitalists (36)
Webinars (12)
Weight loss (248)
Women's health (33)
Worklife (14)
Date
Today (117)
Last 7 days (610)
Last 30 days (3038)
Last 365 days (34906)
2025 (6528)
2024 (36147)
2023 (41177)
2022 (52421)
2021 (57150)
2020 (55984)
2019 (48913)
2018 (37051)
2017 (33844)
2016 (33679)
2015 (39742)
2014 (33454)
2013 (28779)
2012 (31068)
2011 (31677)
2010 (30044)
Location
Africa (802)
Alabama (49)
Alaska (7)
Arizona (223)
Arkansas (13)
Asia (40882)
Australia (6755)
California (5234)
Canada (1809)
China (439)
Colorado (245)
Connecticut (265)
Delaware (120)
Europe (88694)
Florida (775)
Georgia (188)
Idaho (61)
Illinois (507)
India (22)
Indiana (290)
Iowa (7)
Japan (131)
Kansas (102)
Kentucky (24)
Louisiana (8)
Maine (60)
Maryland (831)
Massachusetts (4016)
Michigan (211)
Minnesota (368)
Mississippi (2)
Missouri (74)
Montana (27)
Nebraska (25)
Nevada (56)
New Hampshire (67)
New Jersey (1503)
New Mexico (29)
New York (1500)
North Carolina (948)
North Dakota (7)
Northern California (2282)
Ohio (184)
Oklahoma (13)
Oregon (33)
Pennsylvania (1184)
Puerto Rico (6)
Rhode Island (26)
South America (1192)
South Carolina (17)
South Dakota (1)
Southern California (1973)
Tennessee (89)
Texas (776)
Utah (163)
Virginia (125)
Washington D.C. (60)
Washington State (511)
West Virginia (3)
Wisconsin (46)
734,292 Results for "shape memory medical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Shape Memory Medical Announces European Enrollment in the AAA-SHAPE Randomized Controlled Pivotal Trial
February 20, 2025
·
3 min read
Biotech Bay
Shape Memory Medical Announces First Patient Treated in the AAA-SHAPE Randomized Controlled Pivotal Trial
Shape Memory Medical Inc. announced the first patient treated as part of the AAA-SHAPE Pivotal Trial, the Company’s prospective, multicenter, randomized, open-label trial to determine safety and effectiveness of the IMPEDE-FX RapidFill® Device to improve abdominal aortic aneurysm (AAA) sac behavior when used with elective endovascular aneurysm repair (EVAR).
June 3, 2024
·
3 min read
Biotech Bay
Shape Memory Medical Completes $38 Million in Financing to Advance Endovascular Embolization
Shape Memory Medical Inc., developer of custom shape memory polymers for endovascular markets, announced today that it has completed $38 million in Series C financing.
March 4, 2024
·
4 min read
Editorial
The Shape of a Pandemic: Boom, Bust and Recover
As we reflect on five years of COVID-19, it’s clear that the impacts are still unfolding. The life sciences—and we as individuals—will never be the same again.
March 11, 2025
·
6 min read
·
Jef Akst
Biotech Bay
Shape Memory Medical Announces Publication of Study Results in Vascular
Shape Memory Medical Inc., developer of shape memory polymer for peripheral and neurovascular markets, announced the publication of results from the Company’s prospective, open-label, single-arm, safety study of the IMPEDE Embolization Plug in peripheral vascular embolization.
May 30, 2023
·
3 min read
Biotech Bay
Shape Memory Medical Receives FDA IDE Approval to Initiate AAA-SHAPE, a Head-to-Head Trial
Shape Memory Medical Inc announced that the Food and Drug Administration (FDA) granted investigational device exemption (IDE) for the company to begin a prospective, multicenter, randomized, open-label trial to determine safety and effectiveness of the IMPEDE-FX RapidFill® Device to improve abdominal aortic aneurysm (AAA) sac behavior when used with elective endovascular aneurysm repair (EVAR).
September 7, 2023
·
4 min read
Drug Development
The Political Shape of the Future Clinical Trial Space
In this episode, Lori and guests discuss the pursuit of adequate representation and how clinical trials are being shaped by the legal environment they operate within.
August 1, 2024
·
1 min read
·
Lori Ellis
Biotech Beach
OASIS Medical Inc. Brings a New Shape to Punctal Occlusion
OASIS® Medical Inc., manufacturer and distributor of disposable surgical solutions and dry eye solution brands Oasis TEARS® and SOFT PLUG® punctal plugs launch the SOFT PLUG® Extended Duration 180-T Tapered Plug at ASCRS booth 2675 in Boston.
April 6, 2024
·
3 min read
3 Major Product Releases at 3Shape Discover Event
3Shape announces the launch of three exciting solutions at its 3Shape Discover digital dentistry event.
June 7, 2024
·
3 min read
Business
Shape Therapeutics Appoints Healthcare Industry Leaders David Epstein and Todd Simpson to its Board of Directors
Shape Therapeutics, Inc., a leader at the convergence of AI and RNA editing to revolutionize genomic medicine, announces the appointments of David Epstein, former CEO of Seagen, and Todd Simpson, former CFO of Seagen, to its board of directors.
June 25, 2024
·
3 min read
1 of 73,430
Next